Case Study

Zentiva: Growing into a regional pharmaceutical powerhouse

19 pages
March 2022
Reference: IMD-7-2270

By 2021, Zentiva relied on an internationally diversified network of manufacturing sites, ensuring the production and supply of medicines to millions of people in Europe and beyond. Employing more than 2,300 employees in its wholly owned sites, primarily in Eastern Europe, Zentiva produced medicines that were sold in more than 40 countries. Against the backdrop of changes in the pharma industry – particularly in Europe and in the leading generics market players, which were focused on gaining scale to reduce manufacturing and distribution costs – Zentiva had bold ambitions to become a leading generics and over-the-counter (OTC) manufacturer in Europe by 2025. How could Zentiva derive the benefits of the transformational trends that were impacting pharma players around the world? In view of the changes characterizing the European landscape, would an almost exclusive focus on Eastern Europe be the optimal international growth strategy for the company going forward?

Learning Objective
  • Analyze the extent to which the pharmaceutical industry is transforming itself and how this is creating new opportunities and challenges for incumbents such as Zentiva
  • Analyze the extent to which international expansion can be instrumental in Zentiva’s growth and success in the marketplace
  • Explore how companies such as Zentiva can create value via their international footprint
  • Explore strategy in an environment characterized by a high degree of uncertainty
Keywords
Growth Strategy, International Strategy, Internationalization, Mergers and Acquisitions, Pharmaceuticals
Settings
Czech Republic
Zentiva, Healthcare, Pharmaceuticals
2019-2022
Type
Published Sources
Copyright
© 2022
Available Languages
English
Case clearing houses
Contact

Research Information & Knowledge Hub for additional information on IMD publications

This case study is part of a series
  • Ducati: Adding value abroad in a post-pandemic world?
  • Kellogg: Localizing foreign entry mode
  • Tesla’s global expansion: Where to go next?
  • Zentiva: Growing into a regional pharmaceutical powerhouse
This case study is part of a series
  • Ducati: Adding value abroad in a post-pandemic world?
  • Kellogg: Localizing foreign entry mode
  • Tesla’s global expansion: Where to go next?
  • Zentiva: Growing into a regional pharmaceutical powerhouse
Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics
Ducati: Adding value abroad in a post-pandemic world?
By David Bach Niccolò Pisani and Lisa Simone Duke
Case reference: IMD-7-2267 ©2021
Summary
Ducati’s high performance “Made in Italy” motorcycles, spare parts and apparel targeted the high- and premium-end of the market. Described as “the ...
Reference IMD-7-2267
Copyright ©2021
Copyright owner IMD Copyright
Organization Ducati
Industry Automotive, Motorcycles
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Kellogg: Localizing foreign entry mode
By David Bach Niccolò Pisani and Lisa Simone Duke
Case reference: IMD-7-2269 ©2021
Summary
For more than 100 years, the Kellogg Company of Battle Creek, Michigan, had sold its breakfast cereals around the globe to consumers. With mounting...
Reference IMD-7-2269
Copyright ©2021
Copyright owner IMD Copyright
Organization Kellogg
Industry Consumer Goods, Food and Beverage
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Tesla’s global expansion: Where to go next?
By David Bach Niccolò Pisani and Lisa Simone Duke
Case reference: IMD-7-2268 ©2021
Summary
Tesla set out to build “awesome” electric vehicles with a mission to accelerate the world’s transition to sustainable energy. In so doing, Tesla no...
Reference IMD-7-2268
Copyright ©2021
Copyright owner IMD Copyright
Organization Tesla
Industry Automotive
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Zentiva: Growing into a regional pharmaceutical powerhouse
By David Bach Niccolò Pisani and Lisa Simone Duke
Case reference: IMD-7-2270 ©2022
Summary
By 2021, Zentiva relied on an internationally diversified network of manufacturing sites, ensuring the production and supply of medicines to millio...
Reference IMD-7-2270
Copyright ©2022
Copyright owner IMD Copyright
Organization Zentiva
Industry Healthcare, Pharmaceuticals
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications